A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 9,500 shares of MEDP stock, worth $3.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,500
Previous 38,300 75.2%
Holding current value
$3.47 Million
Previous $15.5 Million 74.73%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$372.0 - $424.34 $31.1 Million - $35.5 Million
-83,736 Reduced 89.66%
9,655 $3.98 Million
Q1 2024

May 15, 2024

BUY
$284.87 - $413.31 $24.9 Million - $36.1 Million
87,313 Added 1436.54%
93,391 $37.7 Million
Q4 2023

Feb 14, 2024

SELL
$227.52 - $312.68 $7.09 Million - $9.75 Million
-31,178 Reduced 83.69%
6,078 $1.86 Million
Q3 2023

Nov 14, 2023

SELL
$233.98 - $281.67 $8.23 Million - $9.9 Million
-35,159 Reduced 48.55%
37,256 $9.02 Million
Q2 2023

Aug 14, 2023

BUY
$187.26 - $240.17 $13.2 Million - $16.9 Million
70,271 Added 3277.57%
72,415 $17.4 Million
Q1 2023

May 15, 2023

SELL
$174.31 - $239.52 $7.31 Million - $10.1 Million
-41,965 Reduced 95.14%
2,144 $403,000
Q4 2022

Feb 14, 2023

BUY
$153.06 - $226.57 $6.33 Million - $9.37 Million
41,354 Added 1501.05%
44,109 $9.37 Million
Q3 2022

Nov 14, 2022

SELL
$145.13 - $182.49 $1.48 Million - $1.86 Million
-10,219 Reduced 78.77%
2,755 $433,000
Q2 2022

Aug 15, 2022

BUY
$130.2 - $168.03 $639,412 - $825,195
4,911 Added 60.91%
12,974 $1.94 Million
Q1 2022

May 16, 2022

SELL
$138.87 - $214.31 $3.04 Million - $4.7 Million
-21,917 Reduced 73.11%
8,063 $1.32 Million
Q4 2021

Feb 14, 2022

BUY
$182.74 - $227.9 $5.01 Million - $6.25 Million
27,437 Added 1078.92%
29,980 $6.52 Million
Q3 2021

Nov 15, 2021

SELL
$170.18 - $198.21 $3.35 Million - $3.9 Million
-19,687 Reduced 88.56%
2,543 $481,000
Q1 2021

May 17, 2021

SELL
$132.02 - $168.26 $2.56 Million - $3.26 Million
-19,356 Reduced 46.54%
22,230 $3.65 Million
Q4 2020

Feb 16, 2021

BUY
$109.38 - $149.19 $1.4 Million - $1.9 Million
12,763 Added 44.28%
41,586 $5.79 Million
Q3 2020

Nov 16, 2020

BUY
$92.95 - $130.61 $2.1 Million - $2.96 Million
22,629 Added 365.34%
28,823 $3.22 Million
Q2 2020

Aug 14, 2020

SELL
$68.08 - $95.68 $377,027 - $529,875
-5,538 Reduced 47.2%
6,194 $576,000
Q1 2020

May 15, 2020

BUY
$61.71 - $101.95 $285,779 - $472,130
4,631 Added 65.22%
11,732 $861,000
Q2 2019

Aug 14, 2019

SELL
$53.64 - $65.42 $724,730 - $883,889
-13,511 Reduced 65.55%
7,101 $464,000
Q1 2019

May 15, 2019

BUY
$49.38 - $70.58 $98,118 - $140,242
1,987 Added 10.67%
20,612 $0
Q4 2018

Feb 14, 2019

SELL
$46.97 - $63.98 $14.4 Million - $19.6 Million
-307,083 Reduced 94.28%
18,625 $985,000
Q3 2018

Nov 13, 2018

BUY
$43.25 - $63.74 $6.86 Million - $10.1 Million
158,502 Added 94.79%
325,708 $0
Q2 2018

Aug 10, 2018

BUY
$34.03 - $45.46 $5.48 Million - $7.32 Million
161,099 Added 2637.94%
167,206 $0
Q1 2018

May 11, 2018

SELL
$32.03 - $39.05 $80,427 - $98,054
-2,511 Reduced 29.14%
6,107 $213,000
Q4 2017

Feb 09, 2018

SELL
$32.46 - $38.31 $438,696 - $517,759
-13,515 Reduced 61.06%
8,618 $312,000
Q3 2017

Nov 09, 2017

BUY
$27.43 - $33.11 $607,108 - $732,823
22,133
22,133 $706,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $11.4B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.